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Background: Trichomoniasis and recurrent urinary tract infections (UTIs) shared similar risk
factors, age distribution and overlapping symptoms. The aim of this study was to deter-
mine the prevalence of Trichomonas vaginalis (TV) in women with recurrent UTIs, attending
a urology clinic in a medical center, in order to inform screening and treatment policies.
Methods: Women with recurrent UTIs, defined as the presence of lower urinary tract
symptoms (dysuria, frequency and urgency) and three positive urine cultures on voided
urine specimens in the previous year, were enrolled prospectively from January 2013 to
April 2014. Urine samples were collected for culture and tested for TV using immuno-
chromatographic strip. Outpatient follow-up was arranged to diagnose any symptomatic
UTI recurrence.
Results: Sixty-five women were recruited. Mean age was 57.4 ± 14.3 year-old and follow-up
duration was 9.5 ± 4.0 months. The prevalence of TV was 16.9% (11/65). Eight women had
UTI recurrence in the follow-up period. Recurrence rate did not differ in patients with and
without concomitant TV infection.
Conclusions: Given the high prevalence of TV, we suggest that testing for TV should be
considered in women with recurrent UTIs. Further larger studies are needed to evaluate
the potential benefit of treating TV in this group of patients.gy, Chang Gung Memorial Hospital at Linkou, 5, Fusing St., Gueishan, Taoyuan 333, Taiwan.
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Scientific background on the subject
Trichomoniasis and recurrent urinary tract infections
(rUTIs) shared similar risk factors, age distribution and
overlapping symptoms. The prevalence of Trichomonas
vaginalis (TV) infection in female patients with rUTIs,
and the potential benefit of treating TV in them remain
unknown.
What this study adds to the field
In the 65 patients with rUTIs, TV infection was found in
16.9% of them. Recurrence rate during the follow-up
period did not differ in patients with and without TV
infection. Given the high prevalence of TV, we suggest
that testing for TV should be considered in women with
rUTIs.Trichomonas vaginalis (TV) is the most prevalent non-viral
sexually transmitted infection (STI) in women [1]. According
to the World Health Organization, over 248 million new cases
of TV infections develop each year and around 8% of women
are infected with TV worldwide [2]. Over 80% of TV infections
are asymptomatic, however symptoms can appear weeks,
months or even years after the initial infection [1,3]. Tricho-
moniasis is associated with a variety of adverse health effects
including the acquisition and transmission of human immu-
nodeficiency virus (HIV), infertility, pelvic inflammatory dis-
ease, cervical intraepithelial neoplasia, and preterm delivery
[1,4e6]. Despite the large number of cases and the poten-
tially severe health impact, it has long been regarded as a STI
of minor importance from both clinical and public health
points of view [3]. Unlike other STIs which aremore frequently
seen in the most sexually active women, the prevalence of TV
peaks among women aged 51e60 years, followed by those
aged over 60 years [7].
Urinary tract infections (UTIs) are the most common adult
bacterial infections in the outpatient setting. Approximately
80% of all UTIs occur in women, andmore than 50% of women
experience at least one UTI during their lifetime [8]. Many
women experience recurrence of a UTI within the first few
months of the initial episode, with reported rates of recur-
rence ranging from 27% to 44% [9,10]. Postmenopausal women
are more susceptible to recurrent UTIs due to the loss of the
protective benefits of estrogen, with a resultant increase in
vaginal pH and decrease in introital Lactobacillus colonization
[11]. In the primary care setting, 53% of women above the age
of 55 years and 36% of younger women report recurrence
within 1 year [10]. Although several mechanisms have been
postulated, managing women with recurrent UTIs remains a
challenge because of increasing antimicrobial resistance and
a lack of effective preventive methods.
In the era of modern diagnostic techniques, commercial
kits using nucleic acid amplification and rapid antigen
detection have been developed for a variety of diseases,
including TV, and the quality of diagnosis has significantlyimproved [6]. In our experience, some patients with a history
of frequent UTIs are co-infected with TV, although they
complain of only urinary symptoms. Given that these two
diseases tend to occur in women of the same age group, we
hypothesized that women with recurrent UTIs may have a
higher prevalence of TV infection, and that treating the
existing TV infection may decrease the recurrence of UTIs.
The objective of this studywas to investigate the prevalence of
concomitant TV infections in a cohort of women with recur-
rent UTIs, and the potential benefit of treating the TV infection
in these patients.Materials and methods
From January 2013 to April 2014, women with a history of
recurrent UTIs who visited our urological outpatient clinic in a
tertiary hospital in northern Taiwan were prospectively
enrolled. This study was approved by the Human Ethics
Committee of our hospital (Chang Gung Medical Foundation
Institutional Review Board, Permit No. 104-1533B). A recurrent
UTI was defined as the presence of lower urinary tract
symptoms (dysuria, frequency or urgency) and three positive
urine cultures on voided urine specimens in the previous
12 months [12]. The patients visited the clinic due to a current
UTI or for consultation for UTI problems during asymptomatic
periods. All of the patients underwent a complete evaluation
including a detailed history and a physical examination
focusing on the urogenital system. Symptoms of overactive
bladder (OAB), also known as urgencyefrequency syndrome,
were recorded according to the International Continence So-
ciety definition, which states “urgency, with or without urge
incontinence, usually with frequency and nocturia [13].”Urine
analysis and microscopic examination, bacterial cultures and
urine Trichomonas rapid tests (Jei Daniel Biotech, Jinan, China)
were performed on all patients. The Trichomonas rapid test kit
is a US FDA-registered, immunochromatographic strip test
using specific antibodies to detect Trichomonas protein anti-
gens [6]. For the patients who tested positive for TV, metro-
nidazole 500 mg orally twice a day for 1 week was prescribed.
Other anti-bacterial antibiotics were also administered
empirically or according to the latest sensitivity results
available. The administration of antibiotics and/or metroni-
dazole according to culture results continued if the patient
had persistent symptoms of dysuria. Outpatient follow-up
visits were scheduled for 4 weeks, 8 weeks and every
3 months thereafter. The patients were asked to repeat urine
culture on follow-up visits if any UTI symptoms had recurred.
If these follow-up cultures turned to be positive, the patients
were considered to have recurrence of UTI during the follow-
up period. In the patients who tested positive for TV, Tricho-
monas rapid tests were repeated for a test-of-cure 4 weeks
after completing treatment.
A urine culture with at least 105 colony-forming units/mL
of uropathogenic bacteria was considered significant.
Commonly accepted uropathogens included enteric gram-
negative rods, enterococci, Staphylococcus saprophyticus and
group B streptococci [14]. We defined antibiotic resistant
strains as those resistant to at least two kinds of different
Table 1 e Characteristics of the patients with recurrent urinary tract infections with and without concomitant Trichomonas
vaginalis (TV) infections (n ¼ 65).
Characteristics All With concomitant TV infection
(n ¼ 11)
Without concomitant TV infection
(n ¼ 54)
p
Value
Mean age in years (SD) 57.4 (14.3) 53.2 (12.1) 58.3 (14.7) .29
Mean follow-up duration in months
(SD)
9.5 (4.0) 7.8 (5.2) 9.8 (3.6) .12
Menopause 46 (70.8) 6 (54.5) 40 (74.1) .17
Increased vaginal discharge/
leucorrhea
18 (27.7) 5 (45.5) 13 (24.1) .07
OAB symptoms 35 (53.8) 4 (36.4) 31 (63.6) .17
Symptomatica 49 (75.4) 9 (81.8) 40 (74.1) .29
Median days of symptom onset
(range)b
7 (1e45) 10 (2e45) 7 (1e30) .88
Dysuriab 42 (85.7) 8 (88.9) 34 (85.0) .38
Frequencyb 34 (69.4) 6 (66.7) 28 (70.0) .42
Urgencyb 19 (38.8) 4 (44.4) 15 (37.5) .35
Hematuriab 14 (28.6) 1 (11.1) 13 (32.5) .10
Microscopy on urine sediment
RBC > 20/uL 20 5 15 .12
WBC > 30/uL 33 6 27 .39
Epithelial > 30/uL 3 2 1 .04
Bacteriuria 40 9 31 .13
Values are no. (%) of patients except as indicated.
Abbreviations: OAB: overactive bladder; RBC: red blood cell; WBC: white blood cell.
a Patients having active symptoms of urinary tract infection when seeking medical help.
b Values are no. (%) of symptomatic patients (n ¼ 49).
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roquinolone or trimethoprimesulfamethoxazole.
All patients were recruited for the prevalence survey.
However, patients were excluded from analysis of the treat-
ment outcome if they were diabetic or had other known
neurogenic disorders, anatomical abnormalities, obstruction
or malignancy of the urological system, and if they had pre-
viously undergone pelvic surgery or an anti-incontinence
procedure. The patients who had been hospitalized for any
etiology or urethral catheterization within 1 month were also
excluded. However, the patients with asymptomatic upper
urinary tract calculi with no obstructive uropathywho had not
undergone an intervention in the past 12 months were not
eliminated from the outcome analysis.
Data are presented as mean ± standard deviation, median
or percentage depending on the variable. Patient character-
istic variables in each group were compared by one-way
analysis of variance. The Student's t-test and chi-square test
were used to compare differences between groups. A p value
of less than .05 was considered to be statistically significant.Results
A total of 65 womenwith recurrent UTIs were recruited for the
prevalence survey. The mean age of these patients was
57.4 ± 14.3 years (range 24e90 years) and 70.8% (46/65) were
postmenopausal. The follow-up duration was
9.5 ± 4.0 months. Eleven (16.9%) of the patients had concom-
itant TV infection and motile trichomonads were found on
microscopic examination in 2 of them. Forty-nine women had
a symptomatic UTI at the first visit. More than half (35/65,53.8%) of the patients had had persistent OAB symptoms for a
long time, and even in the interval between episodes of acute
infection. The clinical characteristics of the patients with and
without concomitant TV infections are shown in [Table 1].
Besides the typical UTI symptoms, 27.7% of the women
complained of increased vaginal discharge and/or leucorrhea
on examination, and this was the only clinical manifestation
that differed between the women with and without concom-
itant TV infection, although the difference was not statisti-
cally significant (45.5% vs. 24.1%; p ¼ 0.07). Gross hematuria
was found in 28.6% of the symptomatic subjects, while
microscopic hematuria was found in 45.5% of the TV infection
group.
Urine cultures were positive for bacterial infection in 33
patients (50.8%), 6 of whom had more than one isolated
microbe. One patient had a mycobacterial infection and one
patient had funguria. Escherichia coli (E. coli) accounted for
76.9% (30/39) of all identified bacteria, and 60.6% (20/33) of the
patients were infected by antibiotic resistant strains, 11 of
which were E. coli with extended-spectrum b-lactamase
[Table 2].
Nine diabetic patients were excluded from outcome anal-
ysis, and three patients with a history of pelvic surgery for
colon cancer, endometrial cancer and urinary incontinence,
and one patient with urinary tuberculosis were also excluded.
In total, 52 women were eligible for outcome analysis. Eight
(15.4%) cases had UTI recurrence during the follow-up period,
87.5% of whom were postmenopausal. Among the women
with UTI recurrence during follow-up period, five were found
to be infected with E. coli at the first visit. The clinical char-
acteristics of the patients with UTI recurrence during the
follow-up period are shown in [Table 3].
Table 2 e Bacteriology results of the patients with
recurrent urinary tract infections with and without
concomitant Trichomonas vaginalis (TV) infection (n¼ 65).
Urine culture
result
All With
concomitant
TV infection
(n ¼ 11)
Without
concomitant
TV infection
(n ¼ 54)
Escherichia coli
Non-ESBL
ESBL
19
11
1
2
18
9
Proteus mirabilis 2 1 1
Citrobacter diversus 1 1 0
Serratia marcescens 1 0 1
Group B
streptococcus
3 1 2
Enterococcus
faecalis
1 0 1
Enterococcus durans 1 0 1
No bacterial
growth
32 7 25
Abbreviation: ESBL: extended-spectrum beta-lactamases.
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history of increased vaginal discharge/leucorrhea, and OAB
symptoms were not significantly different between the pa-
tients with and without recurrence during the follow-up
period.
All of the 11 women with concomitant TV infections were
treated with oral metronidazole. Two of them remained pos-
itive in a test-of-cure after the initial treatment, one of whom
also had a UTI recurrence during the follow-up period.Discussion
Although it has been identified in all ethnic groups and so-
cioeconomic strata, the prevalence of trichomoniasis variesTable 3 e Characteristics of the patients with recurrent
urinary tract infections (UTIs) according to the presence of
UTI recurrence during the follow-up period (n ¼ 52).
Characteristics Free of UTI
recurrence
(n ¼ 44)
UTI
recurrence
(n ¼ 8)
p
Value
Mean age in years (SD) 54.5 (14.2) 60.8 (14.2) .26
Postmenopausal 27 (61.4) 7 (87.5) .15
Increased vaginal
discharge/leucorrhea
13 (29.5) 1 (12.5) .32
OAB symptoms 25 (56.8) 2 (25) .10
Hematuria 10 (22.7) 2 (25) .89
Concomitant TV infection 8 (18.2) 1 (12.5) .35
Isolation of E. coli 17 (38.6) 5 (62.5) .13
Isolation of drug resistant
bacteria from urinea
9 (20.5) 5 (62.5) .09
Values are no. (%) of patients except as indicated.
Abbreviations: OAB: overactive bladder; TV: Trichomonas vagi-
nalis; E. coli: Escherichia coli.
a Bacteria that were resistant to at least two kinds of different
antibiotics, including ampicillin, cephalosporin, fluoroquinolone
or trimethoprimesulfamethoxazole.widely between different populations, ranging from 5.4% in
family planning clinics, 17.3% in patients presenting to sexu-
ally transmitted disease clinics, to 32% among incarcerated
women [3,15]. Reported risk factors for trichomoniasis include
lower socioeconomic status, lower educational level, douch-
ing, and a higher number of lifetime sex partners [16,17].
Epidemiological data on trichomoniasis in Taiwan are scarce.
A large scale survey on women undergoing routine Papani-
colaou smears in urban Taiwan reported that the prevalence
of TVwas 1.88% [17], reaching as high as 3.77% among patients
visiting sexually transmitted disease clinics. Another cross-
sectional study of 269 women attending gynecologic clinics
found that the prevalence of TV infectionwas 7.8% [18]. To the
best of our knowledge, this study is the first to report that the
prevalence of TV in women with recurrent UTIs is 16.9%,
which is two to eight times higher than the reported preva-
lence of TV infection in other populations. This extremely
high prevalence rate suggests that patients with recurrent
UTIs are specifically at risk of TV infections, and the associa-
tion between these two infections is of interest.
Several studies have postulated that TV may serve as a
“vector” for the spread of other pathogens into the genitouri-
nary tract in view of its ability to ingest Neisseria gonorrhoeae,
Mycoplasma, other bacteria, and viruses [19e21]. In addition,
in the pathogenesis of trichomoniasis, TV may cause local
inflammation as the parasite attaches to the mucosa of the
cervix, vagina and urethra. The secretion of cysteine pro-
teinases, a cell-detaching factor, leads to exfoliation of
epithelial cells and breakdown of the structural integrity and
defense barrier of the urogenital tract, making the host more
vulnerable to other urogenital infections, such as HIV [22]. It is
possible that TV also makes the host more vulnerable to
urogenital bacteria, thereby increasing the risk of recurrent
UTIs for patients infected by TV. Therefore, the prevalence of
TV among patients with recurrent UTIs is higher than in other
populations. If TV is treated and the urogenital defense barrier
is repaired, the risk of recurrent UTIs should be decreased.
Two main hypotheses have been put forward to explain
the increased risk of recurrent UTIs in some women. The first
suggests that the local defense mechanisms of these women
are defective and render them more susceptible to periure-
thral colonization [10]. The second suggests that the first
episode causes changes in host resistance [23]. In either case,
it is possible that microbial virulence factors play a less
important role in recurrent UTIs than in the first episode, and
that a defective host resistance mechanism is of more
importance. If either of these hypotheses is true, women with
recurrent UTIs may be more vulnerable to other urogenital
infections, including TV. Elimination of TV may not decrease
the risk of subsequent UTIs.
In our 52 patients of recurrent UTIs, 15.3% (8/52) of them
had UTI recurrence after treatment during the follow-up
period. In order to minimize confounding factors, we
excluded patients with diabetes and those with other uro-
genital or neurological abnormalities from the outcome
analysis, so our recurrence rate is lower than previously re-
ported. Several studies have shown that individuals with
diabetes have an increased relative risk of UTIs compared to
those without diabetes [24]. In the present study, five out of
nine diabetic women had UTI recurrence during the follow-up
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more likely to have UTI recurrence in the follow-up period
(12.5% vs. 18%). For ethical reasons, all of the patients who
tested positive for TV were treated. Breakdown of the local
defense barrier may have been repaired after treating TV,
resulting in the similar recurrence rate in the two groups. We
could not conclude which of the above hypotheses is correct,
and whether the tendency of having recurrent UTIs is caused
by TV infection or determined by the host per se is unknown.
Larger longitudinal cohort studies are needed to elucidate this
issue.
Increased vaginal discharge/leucorrhea was more common
in the patients with concomitant TV infection in this study.
However, the association between symptomatic vaginal
discharge and TV infection is controversial. In a population-
based study, the prevalence of TV infection was not different
between women with or without vaginal symptoms, including
vaginal discharge, itching or odor [16]. In contrast, another
study on women undergoing gynecological examinations
revealed that those infected with TVweremore likely to report
vaginal discharge and leucorrhea [25]. However, only the
womenwith leucorrhea diagnosed bymicroscopy were shown
to have a 4-fold increased risk of TV infection in multivariate
analysis. Because self-reported vaginal discharge is a rather
non-specific symptom, microscopic examination of vaginal
dischargemay help define patientswith pathologic leucorrhea,
and may be needed in future studies.
The presence of hematuria has also been reported to be a
strong predictor of recurrent UTIs [26]. Erythrocytes provide
essential nutrients needed by TV such as fatty acids and iron
[27]. Iron can be obtained by hemoglobin degradation after the
lysis of erythrocytes, which also requires cysteine proteinase
activity. In a clinical scenario, the symptoms and signs of TV
infection can fluctuate andworsen around the time ofmenses
[27]. Hematuria, either gross or microscopic, bears abundant
erythrocytes and may foster the growth of these parasites.
Microscopic hematuria was more frequently seen in our pa-
tients with TV infection compared with those without TV
(45.5% vs. 27.8%), though the difference did not reach statis-
tical significance.
According to the recommendations of the United States
Centers for Disease Control and Prevention, all women
seeking care for symptoms of vaginal discharge should be
tested for TV infection [28]. However, the high rate of
asymptomatic TV infections in women supports the idea that
clinicians should not limit evaluations for trichomoniasis to
symptomatic, more specifically vaginal discharge, patients
alone [16]. Because UTIs and STIs share similar risk factors,
age distribution and overlapping symptoms, it is usually
difficult to differentiate these two infectionsmerely by clinical
manifestations [29,30]. Furthermore, several studies have
demonstrated that around 20% of adultwomenwith a culture-
proven UTI have concomitant vaginal or cervical infection
with sexually transmitted organisms, including TV [30]. In this
pilot study, we found a higher prevalence of TV among the
women with recurrent UTI. Therefore, to improve the detec-
tion and treatment of TV infection, we suggest that testing for
TV should be considered for women with recurrent UTIs, and
that there is a need for further larger scale studies to investi-
gate the possible benefits of treating TV in these patients.There are some limitations to this study. First, only
immunochromatographic antigen tests were used to diagnose
TV infection. It has been reported that compared with wet
mount, the test kit used in this study (Jei Daniel Biotech, Jinan,
China) has a sensitivity of 100% and specificity of 88% when
used on urogenital specimens [31]. These point-of-care test
kits are easy to perform and the results are quickly available,
however the sensitivity is not as good as with nucleic acid
amplification tests and some cases will be undiagnosed,
especially those that are asymptomatic with presumably a
lower organism burden [6]. The use of such kits may lead to
underestimation of the true prevalence. Second, information
on the patients’ sexual history was minimal or lacking. We
were unable to carefully assess the relationship between sex-
ual intercourse and recurrentUTIs becauseof the reluctance of
our patients to discuss sexual practices. Third, we do not have
a control group of healthy female. However, compared with
previously reported prevalence of TV in Taiwanese women
undergoing routine smears, it is highly possible that women
with recurrent UTIs do have higher prevalence of TV.
Despite these limitations, this report represents a relevant
contribution to the epidemiology of TV among patients with
recurrent UTIs. We suggest that women with recurrent UTIs
are specifically at risk of TV infection. Screening and treat-
ment strategies for these women should be established. Our
findings also highlight the interaction between TV, uropa-
thogenic bacteria and susceptible hosts. Future research
focusing on these issues will enhance our understanding of
trichomoniasis, and make effective prevention possible.Conflicts of interest
The authors declare that they have no competing interests.r e f e r e n c e s
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